These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


434 related items for PubMed ID: 21745524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X, Xing Y, Guo L, Lv X, Song H, Xi T.
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX, Qiu YY, Zhao YH, Liu XT, Liu M, Yu AL.
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Yang XL, Liu WC, Yang WW, Zhong D, Liu YH, Zhang JD, Jiang JH, Li SS.
    Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L, Liu K, Xu G, Li X, Tu J, Tang F, Xing Y, Xi T.
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
    [Abstract] [Full Text] [Related]

  • 10. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
    Lü L, Cao HD, Zeng HQ, Wang PL, Wang LJ, Liu SN, Xiang TX.
    Vaccine; 2009 Feb 11; 27(7):972-8. PubMed ID: 19111590
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected mice.
    Chen J, Lin M, Li N, Lin L, She F.
    Vaccine; 2012 Aug 03; 30(36):5310-5. PubMed ID: 22749593
    [Abstract] [Full Text] [Related]

  • 12. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W, Wu W, Xu X.
    Vaccine; 2007 Nov 01; 25(44):7664-73. PubMed ID: 17913305
    [Abstract] [Full Text] [Related]

  • 13. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J, Dai LX, Pan X, Wang H, Li B, Zhu J, Li MY, Shi XL, Wang BN.
    Pathog Dis; 2015 Jul 01; 73(5):. PubMed ID: 25846576
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on H. pylori Infection in Mongolian gerbils.
    Guo L, Yang H, Tang F, Yin R, Liu H, Gong X, Wei J, Zhang Y, Xu G, Liu K.
    Front Cell Infect Microbiol; 2017 Jul 01; 7():349. PubMed ID: 28824883
    [Abstract] [Full Text] [Related]

  • 17. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
    Flach CF, Svensson N, Blomquist M, Ekman A, Raghavan S, Holmgren J.
    Vaccine; 2011 Feb 01; 29(6):1235-41. PubMed ID: 21147129
    [Abstract] [Full Text] [Related]

  • 18. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling.
    Lucas B, Bumann D, Walduck A, Koesling J, Develioglu L, Meyer TF, Aebischer T.
    Infect Immun; 2001 Mar 01; 69(3):1714-21. PubMed ID: 11179348
    [Abstract] [Full Text] [Related]

  • 19. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J, Svennerholm AM.
    Vaccine; 2007 Mar 30; 25(14):2591-8. PubMed ID: 17239498
    [Abstract] [Full Text] [Related]

  • 20. Systemic immune responses to oral administration of recombinant attenuated Salmonella typhimurium expressing Helicobacter pylori urease in mice.
    Liu XF, Hu JL, Quan QZ, Sun ZQ, Wang YJ, Qi F.
    World J Gastroenterol; 2005 Apr 14; 11(14):2154-6. PubMed ID: 15810083
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.